Associated Papers
Proteogenomic Profiling of Treatment-Naïve Metastatic Malignant Melanoma.
Kuras M et al.
Cancers, 2025
ACE Phenotyping in Human Blood and Tissues: Revelation of ACE Outliers and Sex Differences in ACE Sialylation.
Enyedi EE et al.
Biomedicines, 2024
Evaluation of genetic risk, its clinical manifestation and disease management based on 18 susceptibility gene markers among West-Slavonic patients with sarcoidosis.
Kishore A et al.
Gene, 2023
Pharmacovariome scanning using whole pharmacogene resequencing coupled with deep computational analysis and machine learning for clinical pharmacogenomics.
Tafazoli A et al.
Human Genomics, 2023
Functional link between sarcoidosis-associated gene variants and quantitative levels of bronchoalveolar lavage fluid cell types.
Abo Al Hayja M et al.
Frontiers in Medicine, 2023
Expanding the prostate cancer cell line repertoire with ACRJ-PC28, an AR-negative neuroendocrine cell line derived from an African-Caribbean patient.
Valentine H et al.
Cancer Research Communications, 2022
ANXA11 rs1049550 Associates with Löfgren's Syndrome and Chronic Sarcoidosis Patients.
Karakaya B et al.
Cells, 2022
ANXA11 mutations are associated with amyotrophic lateral sclerosis-frontotemporal dementia.
Wang Y et al.
Frontiers in Neurology, 2022
A synergetic effect of BARD1 mutations on tumorigenesis.
Li W et al.
Nature Communications, 2021
ANXA11 mutations in ALS cause dysregulation of calcium homeostasis and stress granule dynamics.
Nahm M et al.
Science Translational Medicine, 2020
Association of TGF-β3 and ANXA11 with pulmonary sarcoidosis in Greek population.
Sikorova K et al.
Expert Review of Respiratory Medicine, 2020
Current Insights in Genetics of Sarcoidosis: Functional and Clinical Impacts.
Calender A et al.
Journal of Clinical Medicine, 2020
Novel Dominant KCNQ2 Exon 7 Partial In-Frame Duplication in a Complex Epileptic and Neurodevelopmental Delay Syndrome.
Lazo PA et al.
International Journal of Molecular Sciences, 2020
Pharmacogenomics, biomarker network, and allele frequencies in colorectal cancer.
López-Cortés A et al.
The Pharmacogenomics Journal, 2020
Extensive disruption of protein interactions by genetic variants across the allele frequency spectrum in human populations.
Fragoza R et al.
Nature Communications, 2019
Two rare variants of the ANXA11 gene identified in Chinese patients with amyotrophic lateral sclerosis.
Liu X et al.
Neurobiology of Aging, 2019
ANXA11 mutations prevail in Chinese ALS patients with and without cognitive dementia.
Zhang K et al.
Neurology. Genetics, 2018
Whole exome sequencing in three families segregating a pediatric case of sarcoidosis.
Calender A et al.
Bmc Medical Genomics, 2018
Next-Generation Sequencing Based HLA Typing: Deciphering Immunogenetic Aspects of Sarcoidosis.
Kishore A et al.
Frontiers in Genetics, 2018
Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis.
Smith BN et al.
Science Translational Medicine, 2017
Novel compound heterozygous MYO7A mutations in Moroccan families with autosomal recessive non-syndromic hearing loss.
Bakhchane A et al.
Plos One, 2017
The chronological sequence of somatic mutations in early gastric carcinogenesis inferred from multiregion sequencing of gastric adenomas.
Lim CH et al.
Oncotarget, 2016
TNFA, ANXA11 and BTNL2 Polymorphisms in CVID Patients with Granulomatous Disease.
Boutboul D et al.
Journal of Clinical Immunology, 2016
Identification of Immune-Relevant Factors Conferring Sarcoidosis Genetic Risk.
Fischer A et al.
American Journal of Respiratory and Critical Care Medicine, 2015
Evaluation of Hybridization Capture Versus Amplicon-Based Methods for Whole-Exome Sequencing.
Samorodnitsky E et al.
Human Mutation, 2015
Granuloma genes in sarcoidosis: what is new?
Fischer A et al.
Current Opinion in Pulmonary Medicine, 2015
Identification of cancer predisposition variants in apparently healthy individuals using a next-generation sequencing-based family genomics approach.
Karageorgos I et al.
Human Genomics, 2015
The eSNV-detect: a computational system to identify expressed single nucleotide variants from transcriptome sequencing data.
Tang X et al.
Nucleic Acids Research, 2014
Annexin A11 (ANXA11) gene polymorphisms are associated with sarcoidosis in a Han Chinese population: a case-control study.
Feng X et al.
Bmj Open, 2014
Annexin A11 gene polymorphism (R230C variant) and sarcoidosis in a Portuguese population.
Morais A et al.
Tissue Antigens, 2013
Association of ANXA11 genetic variation with sarcoidosis in African Americans and European Americans.
Levin AM et al.
Genes and Immunity, 2013
Fine-mapping in African-American women confirms the importance of the 10p12 locus to sarcoidosis.
Cozier YC et al.
Genes and Immunity, 2012
Functional variant ANXA11 R230C: true marker of protection and candidate disease modifier in sarcoidosis.
Mrazek F et al.
Genes and Immunity, 2011
Novel chemosensitive single-nucleotide polymorphism markers to targeted regimens in metastatic colorectal cancer.
Kim JC et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2011
A genome-wide admixture scan for ancestry-linked genes predisposing to sarcoidosis in African-Americans.
Rybicki BA et al.
Genes and Immunity, 2011
Characterisation of the sarcoidosis-associated variant of annexin A11.
Fatimathas L et al.
General Physiology and Biophysics, 2009
Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis.
Hofmann S et al.
Nature Genetics, 2008
Genome bioinformatic analysis of nonsynonymous SNPs.
Burke DF et al.
Bmc Bioinformatics, 2007